Stephens & Co. Maintains Overweight on CareDx, Raises Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Mason Carrico maintains an Overweight rating on CareDx (NASDAQ:CDNA) and raises the price target from $15 to $18.
May 13, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CareDx's price target has been raised from $15 to $18 by Stephens & Co., with an Overweight rating maintained by analyst Mason Carrico.
The increase in price target by a reputable analyst firm like Stephens & Co. typically signals a positive outlook on the company's future performance, potentially leading to increased investor confidence and a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100